India is seeing a growing number of metabolic disorders, prompting a shift in healthcare towards preventative measures before conditions like obesity, diabetes, PCOS, and thyroid problems worsen. According to Kunal Kapoor, Co-Founder of MetaGO and Ketto, the future of healthcare involves the early detection of metabolic risks through an integration of diagnostics, clinical expertise, technology, and continuous patient engagement. In an interview with The Economic Times Digital, he delves into MetaGO’s business model, the opportunities and challenges associated with GLP-1 therapies, the valuable lessons from his experience with Ketto, and his perspective on why sustained metabolic care, rather than short-term weight loss, is shaping up to be one of India's most substantial health-tech prospects. Edited excerpts.
The Economic Times (ET): You spent more than a decade helping families raise funds for serious medical conditions through Ketto. Was there a specific moment or pattern that convinced you that India needs to move from financing treatment to addressing metabolic health?
